BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27849610)

  • 21. In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure.
    Besaratinia A; Kim SI; Hainaut P; Pfeifer GP
    Gastroenterology; 2009 Sep; 137(3):1127-37, 1137.e1-5. PubMed ID: 19524575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of DNA repair gene polymorphisms and aflatoxin B1 in the risk of hepatocellular carcinoma.
    Yao JG; Huang XY; Long XD
    Int J Clin Exp Pathol; 2014; 7(9):6231-44. PubMed ID: 25337275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification and validation of enzyme immunoassay for urinary aflatoxin B1-N7-guanine adduct for biological monitoring of aflatoxins.
    Nayak S; Sashidhar RB; Bhat RV
    Analyst; 2001 Feb; 126(2):179-83. PubMed ID: 11235100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity and single-strand DNA break repair in Chinese hamster mutants exposed to the carcinogen aflatoxin B1 epoxide and its dichloride model.
    Martin EA; Waters R
    Mutat Res; 1992 May; 273(3):243-51. PubMed ID: 1374845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma.
    Long XD; Zhao D; Wang C; Huang XY; Yao JG; Ma Y; Wei ZH; Liu M; Zeng LX; Mo XQ; Zhang JJ; Xue F; Zhai B; Xia Q
    Epidemiology; 2013 Sep; 24(5):671-81. PubMed ID: 23788213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
    Yu MW; Lien JP; Liaw YF; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The aflatoxin B
    Minko IG; Kellum AH; Stone MP; Lloyd RS
    Environ Mol Mutagen; 2024 Apr; 65 Suppl 1(Suppl 1):9-13. PubMed ID: 37303259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Micronuclei, chromosomal aberrations and aflatoxin-albumin adducts in experimental animals after exposure to aflatoxin B1.
    Anwar WA; Khalil MM; Wild CP
    Mutat Res; 1994 Jul; 322(1):61-7. PubMed ID: 7517505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mass Spectrometry-Based Method to Measure Aflatoxin B
    Bellamri M; Yao L; Tomar R; Vartanian V; Rizzo CJ; Stone MP; Groopman JD; Lloyd RS; Turesky RJ
    Chem Res Toxicol; 2024 Apr; 37(4):633-642. PubMed ID: 38498000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA Sequence Modulates the Efficiency of NEIL1-Catalyzed Excision of the Aflatoxin B
    Tomar R; Minko IG; Kellum AH; Voehler MW; Stone MP; McCullough AK; Lloyd RS
    Chem Res Toxicol; 2021 Mar; 34(3):901-911. PubMed ID: 33595290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editor's Highlight: Pregnancy Alters Aflatoxin B1 Metabolism and Increases DNA Damage in Mouse Liver.
    Sriwattanapong K; Slocum SL; Chawanthayatham S; Fedeles BI; Egner PA; Groopman JD; Satayavivad J; Croy RG; Essigmann JM
    Toxicol Sci; 2017 Nov; 160(1):173-179. PubMed ID: 28973694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct synthesis of aflatoxin B1-N7 guanine adduct: a reference standard for biological monitoring of dietary aflatoxin exposure in molecular epidemiological studies.
    Vidyasagar T; Sujatha N; Sashidhar RB
    Food Addit Contam; 1997 Jul; 14(5):457-67. PubMed ID: 9328530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Food restriction reduces aflatoxin B1 (AFB1)-DNA adduct formation, AFB1-glutathione conjugation, and DNA damage in AFB1-treated male F344 rats and B6C3F1 mice.
    Chou MW; Chen W
    J Nutr; 1997 Feb; 127(2):210-7. PubMed ID: 9039820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold.
    Johnson NM; Egner PA; Baxter VK; Sporn MB; Wible RS; Sutter TR; Groopman JD; Kensler TW; Roebuck BD
    Cancer Prev Res (Phila); 2014 Jul; 7(7):658-65. PubMed ID: 24662598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
    Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
    Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Error-prone bypass patch by a low-fidelity variant of DNA polymerase zeta in human cells.
    Suzuki T; Sassa A; Grúz P; Gupta RC; Johnson F; Adachi N; Nohmi T
    DNA Repair (Amst); 2021 Apr; 100():103052. PubMed ID: 33607474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms in the coding region of X-ray repair complementing group 4 and aflatoxin B1-related hepatocellular carcinoma.
    Long XD; Yao JG; Zeng Z; Ma Y; Huang XY; Wei ZH; Liu M; Zhang JJ; Xue F; Zhai B; Xia Q
    Hepatology; 2013 Jul; 58(1):171-81. PubMed ID: 23390017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma antioxidant vitamins, chronic hepatitis B virus infection and urinary aflatoxin B1-DNA adducts in healthy males.
    Yu MW; Chiang YC; Lien JP; Chen CJ
    Carcinogenesis; 1997 Jun; 18(6):1189-94. PubMed ID: 9214602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitation and mapping of aflatoxin B1-induced DNA damage in genomic DNA using aflatoxin B1-8,9-epoxide and microsomal activation systems.
    Denissenko MF; Cahill J; Koudriakova TB; Gerber N; Pfeifer GP
    Mutat Res; 1999 Apr; 425(2):205-11. PubMed ID: 10216213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis.
    Shen HM; Ong CN
    Mutat Res; 1996 Oct; 366(1):23-44. PubMed ID: 8921985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.